SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001654954-23-003945
Filing Date
2023-03-31
Accepted
2023-03-30 17:47:03
Documents
68
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tenx_10k.htm   iXBRL 10-K 1309082
2 DESCRIPTION OF COMMON STOCK. tenx_ex417.htm EX-4.17 44781
3 SUBSIDIARIES tenx_ex211.htm EX-21.1 2400
4 CONSENT tenx_ex231.htm EX-23.1 2459
5 CERTIFICATION tenx_ex311.htm EX-31.1 9246
6 CERTIFICATION tenx_ex312.htm EX-31.2 9460
7 CERTIFICATION tenx_ex321.htm EX-32.1 4669
8 CERTIFICATION tenx_ex322.htm EX-32.2 5159
  Complete submission text file 0001654954-23-003945.txt   5207301

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA tenx-20221231.xsd EX-101.SCH 55376
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tenx-20221231_lab.xml EX-101.LAB 307400
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tenx-20221231_cal.xml EX-101.CAL 38859
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tenx-20221231_pre.xml EX-101.PRE 257930
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tenx-20221231_def.xml EX-101.DEF 142436
62 EXTRACTED XBRL INSTANCE DOCUMENT tenx_10k_htm.xml XML 669289
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34600 | Film No.: 23782030
SIC: 2834 Pharmaceutical Preparations